Renovaro Biosciences Inc. - Common Stock RENB 深 滬
已收盤 09-30 16:00:00 美东时间
1.42
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 1.42
- 總市值 3.28亿
- 52周最高 21.00
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.214
- 委 比 0.00%
- 總股本 2.31亿
- 歷史最高 137.80
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.214
- 每 手 1
- 風險率 2.25%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Renovaro Biosciences Announces Reverse Stock Split
Renovaro Biosciences ( ($RENB) ) just unveiled an update. Lunai Bioworks, Inc. ...
2025-09-25 16:53
Lunai Bioworks to effect 10:1 reverse stock split
Lunai Bioworks (NASDAQ:RENB) announced on Wednesday that the company's Board of Directors has approved a 10:1 reverse stock split of its issued and outstanding common stock, to be effective on Septem...
2025-09-25 04:59
Renovaro Biosciences Faces Subsidiary Bankruptcy Impact
Renovaro Biosciences ( ($RENB) ) just unveiled an announcement. On September 2,...
2025-09-06 05:29
Lunai Bioworks DBA Renovaro Partners With American Defense International To Advance AI-Powered Countermeasures Against Chemical And Biological Threats, Including Highly Toxic Agents Such As Sarin Nerve Gas
Collaboration aims to apply Lunai Bioworks Inc. biomedical AI platform to accelerate countermeasure development for chemical agents like sarin and other biothreatsLOS ANGELES, CALIFORNIA / ACCESS Newswire / September 4,
2025-09-04 22:09
Renovaro To Change Its Corporate Name To Lunai Bioworks Inc., Reflecting Strategic Direction In AI-Powered Biodefense, Drug Discovery And Advanced Diagnostics
Renovaro Inc. (NASDAQ:RENB) today announced that it will change its corporate name to Lunai Bioworks, Inc. to better reflect its strategic direction and growing expertise in AI-powered biodefense, drug discovery and
2025-08-27 21:47
Renovaro Biosciences Granted Nasdaq Compliance Extension
Renovaro Biosciences ( ($RENB) ) has provided an update. Renovaro Inc. received...
2025-08-07 00:18
Renovaro Multiple U.S. Patent Allowances To Bolster Biomedical AI Platform, Including Application No. 18/058,732 For Unbiased Drug Discovery Predictions
Strategic IP expansion protects federated learning technology driving pharma partnerships, biosecurity initiatives, and precision medicine growthLOS ANGELES, CALIFORNIA / ACCESS Newswire / July 28, 2025 / Renovaro
2025-07-28 22:41
Renovaro Biosciences Chairman Announces Resignation
An update from Renovaro Biosciences ( ($RENB) ) is now available. On July 22, 2...
2025-07-26 05:27
Renovaro Biosciences Announces Publication Of Peer-Reviewed Study In Vaccines; Says Preclinical Data Validate Renovaro's Platform Representing Step Forward In Fight Against Pancreatic And Solid Tumors
Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumorsLOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro Biosciences
2025-07-17 21:20
Renovaro Biosciences Receives Nasdaq Compliance Notice
Renovaro Biosciences ( ($RENB) ) has shared an announcement. Renovaro Inc. rece...
2025-07-14 21:43
